How Business Development Optimally Contributes to the Pharmaceutical Value Chain

28 May 2024, 14:00 - 14:45 PM CET (*) 

Free Educational Webinar 
With BD&L Expert Dr. Carlos Velez


Business Development and Licensing (BD&L) activities are essential for pharma companies to keep their pipeline healthy, seize opportunities for revenue diversification, mitigate risk, and realise synergies.

Dr. Carlos Velez

In this webinar, faculty member of Business Development & Licensing Course For Pharma & Biotech, Dr. Carlos Velez, will share his insights on the interplay between BD&L and the pharmaceutical value chain:

  • Overview of the pharmaceutical value chain, a simple but powerful framework

  • How BD&L activities help leverage strengths and address weaknesses across the full value chain

  • Application of the value chain framework to assess strengths and weaknesses at each stage of the BD&L process

 Register now ➤


About Dr. Carlos Velez:

  • Faculty member of CELforPharma, teaching the popular 2-day Business Development & Licensing Course For Pharma & Biotech.

  • Founder and Managing Partner of Lacerta Bio, an international consultancy specialising in both in- and out-licensing of prescription and non-prescription product candidates and commercial products, across multiple therapeutic areas and markets.

  • Prior to that, Carlos built a 10+ years career in senior Business Development roles at Penwest Pharmaceuticals, Lantic Therapeutics Forest Labs, and Genencor (now Danisco).

  • Carlos has trained and consulted life science executives around the world on in- and out-licensing. 

Register now ➤

Please note that this webinar is only open to managers working in pharma/biotech/medtech companies.  For your registration to be approved, please enter your COMPANY EMAIL address.


(*) If you cannot attend the webinar, please note that a recorded playback will be sent to all registrants after the webinar.




Learn more from this expert at the following short duration course(s):